Negative correlation between bone mineral density and TSH receptor antibodies in long-term euthyroid postmenopausal women with treated Graves’ disease
Open accessAbstract
BACKGROUND: Thyrotoxicosis is a cause of secondary osteoporosis. High concentrations of triiodotironine (T3) in Graves' disease stimulate bone turnover, but it is unclear if euthyroidism will always normalize bone metabolism. Thyrotropin (TSH) is known to affect directly the bone metabolism through the TSH receptor and TSH receptor antibodies (TRAb) may have an important role in bone turn-over.The aim of our study was to determine, in pre and postmenopausal euthyroidism patients with previous overt hyperthyroidism due to Graves' disease the bone mineral density (BMD) as well as factors that could affect BMD in each group, including TRAb. METHODS: Cross-sectional, non-interventional study. Fifty-seven patients with previous hyperthyroidism due to Graves' disease (premenopausal: 30, postmenopausal: 27) that remained euthyroid for at least 6 months prior to study were included and compared with fifty- two matched respective controls. Thyrotoxine (T4), TSH, TRAb and BMD were measured. RESULTS: Only euthyroid postmenopausal patients with a history of hyperthyroidism due to Graves' disease showed lower whole body BMD than matched controls. The BMD expressed as Z-score was less in whole body and lumbar spine in postmenopausal in relation to premenopausal women with previous overt hyperthyroidism due to Graves' disease.In the postmenopausal patients, the Z-score of lumbar spine BMD correlated negatively with TRAb (r = -0,53, p < 0.008), positively with the time of evolution of the disease (r = +0.42, p < 0.032) and positively with the time of euthyroidism (r = + 0.50, p < 0.008), but neither with serum T4 nor TSH. In a multiple regression analysis TRAb was the only significant independent variable in relation to lumbar spine BMD (F = 3. 90, p < 0.01). CONCLUSIONS: In euthyroid women with a history of Graves' hyperthyroidism, BMD was only affected in the postmenopausal group. The negative correlation of Z-score of lumbar spine BMD with TRAb suggests that this antibody may affect the bone metabolism.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In euthyroid women with a history of Graves' hyperthyroidism, lumbar spine bone density is negatively associated with TSH receptor antibodies in postmenopausal but not premenopausal women.
“in euthyroid women with a history of Graves’ hyperthyroidism lumbar spine bone density was negatively associated with TSH receptor antibodies in post- but not premenopausal women (102).”
From Levothyroxine therapy in elderly patients with hypothyroidism (2021) · cites this paper as [102]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595 · see citing works
TSH Is a Negative Regulator of Skeletal Remodeling
Abe, E., Marians, R. C., Yu, W., Wu, X.-B., Ando, T., Li, Y., Iqbal, J., Eldeiry, L., Rajendren, G., Blair, H. C., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00771-2 · Cited by 691 · see citing works
Autoimmune Thyroid Disease: Further Developments in Our Understanding*
Weetman, A. P., & McGregor, A. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-6-788 · Cited by 660 · see citing works
ERIKSEN, E. F. (1986) · Endocrine Reviews · doi:10.1210/edrv-7-4-379 · Cited by 601 · see citing works
Bone Mineral Density Changes during the Menopause Transition in a Multiethnic Cohort of Women
Finkelstein, J. S., Brockwell, S. E., Mehta, V., Greendale, G. A., Sowers, M. R., Ettinger, B. B., Lo, J. C.-M., Johnston, J. M., Cauley, J. A., Danielson, M. E., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1876 · Cited by 600 · see citing works
Autoantibodies to the Thyrotropin Receptor
Smith, B. R., McLachlan, S. M., & Furmaniak, J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-106 · Cited by 578 · see citing works
Laurberg, P., Wallin, G., Tallstedt, L., Abraham-Nordling, M., Lundell, G., & Tørring, O. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0450 · Cited by 428 · see citing works
Effects of thyroid hormones on bone and mineral metabolism
Mosekilde, L., Eriksen, E. F., & Charles, P. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30338-4 · Cited by 423 · see citing works
Törring, O., Tallstedt, L., Wallin, G., Lundell, G. E. F., Ljunggren, J. ‐., Taube, A., Sääf, M., & Hamberger, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.8.8768863 · Cited by 311 · see citing works
Vestergaard, P., & Mosekilde, L. (2002) · Thyroid · doi:10.1089/105072502760043503 · Cited by 289 · see citing works
The molecular actions of thyroid hormone in bone
Duncan Bassett, J. H., & Williams, G. R. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00144-9 · Cited by 261 · see citing works
Clinical Utility of TSH Receptor Antibodies
Barbesino, G., & Tomer, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-4309 · Cited by 237 · see citing works
Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption.
Britto, J. M., Fenton, A., Holloway, W. R., & Nicholson, G. (1994) · Endocrinology · doi:10.1210/endo.134.1.8275930 · Cited by 225 · see citing works
Mora, S., Pitukcheewanont, P., KAUFMAN, F. R., Nelson, J. C., & Gilsanz, V. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.10.1664 · Cited by 172 · see citing works
Bone loss in hypothyroidism with hormone replacement. A histomorphometric study.
Coindre, J., David, J., Rivière, L., Goussot, J., Roger, P., de Mascarel, A., & Meunier, P. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.1986.00360130058007 · Cited by 170 · see citing works
Faber, Jensen, Petersen, Nygaard, Hegedüs, & Siersbæk‐Nielsen (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00427.x · Cited by 156 · see citing works
Prevalence of Fractures in Postmenopausal Women with Thyroid Disease
Solomon, B. L., Wartofsky, L., & Burman, K. D. (1993) · Thyroid · doi:10.1089/thy.1993.3.17 · Cited by 150 · see citing works
Bone loss in hypothyroidism with hormone replacement. A histomorphometric study
Coindre, J. M. (1986) · Archives of Internal Medicine · doi:10.1001/archinte.146.1.48 · Cited by 149 · see citing works
Nuclear thyroid hormone receptors in cultured bone cells.
Rizzoli, R., Poser, J., & Bürgi, U. (1986) · Metabolism: Clinical and Experimental · doi:10.1016/0026-0495(86)90098-3 · Cited by 147 · see citing works
Hyperthyroidism, Thyroid Hormone Therapy, and Bone
Ross, D. S. (1994) · Thyroid · doi:10.1089/thy.1994.4.319 · Cited by 146 · see citing works
Krølner, B. K., Jørgensen, J., & Nielsen, S. P. (1983) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1983.tb02873.x · Cited by 145 · see citing works
Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy
Greenspan, S. L., Greenspan, F. S., Resnick, N. M., Block, J. E., Friedlander, A. L., & Genant, H. K. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90066-7 · Cited by 143 · see citing works
Bone metabolism during anti‐thyroid drug treatment of endogenous subclinical hyperthyroidism
Mudde, A. H., Houben, A. J. H. M., & Kruseman, A. C. N. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02571.x · Cited by 135 · see citing works
Persistent Increase in Bone Turnover in Graves’ Patients with Subclinical Hyperthyroidism
Kumeda, Y., Inaba, M., Tahara, H., Kurioka, Y., Ishikawa, T., Morii, H., & Nishizawa, Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6979 · Cited by 123 · see citing works
Thyrotoxic Bone Disease in Women: A Potentially Reversible Disorder
DIAMOND, T. H., Vine, J., Smart, R., & Butler, P. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-1-199401010-00002 · Cited by 119 · see citing works
Rosen, C. J., & Adler, R. A. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464660 · Cited by 110 · see citing works
Takasu, N., & Matsushita, M. (2012) · Journal of Thyroid Research · doi:10.1155/2012/182176 · Cited by 100 · see citing works
The Effects of Recombinant TSH on Bone Turnover Markers and Serum Osteoprotegerin and RANKL Levels
Martini, G., Gennari, L., Paola, V. D., Pilli, T., Salvadori, S., Merlotti, D., Valleggi, F., Campagna, S., Franci, B., Avanzati, A., et al. (2008) · Thyroid · doi:10.1089/thy.2007.0166 · Cited by 91 · see citing works
Hip fractures and the thyroid: a case‐control study
Wejda, B., Hintze, G., Katschinski, B., Olbricht, T., & Benker, G. (1995) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1995.tb01172.x · Cited by 83 · see citing works
Fracture Risk in Patients Treated for Hyperthyroidism
Vestergaard, P., Rejnmark, L., Weeke, J., & Mosekilde, L. (2000) · Thyroid · doi:10.1089/thy.2000.10.341 · Cited by 80 · see citing works
Bone mineral density in hyperthyroidism
Karga, H., Papapetrou, P. D., Korakovouni, A., Papandroulaki, F., Polymeris, A., & Pampouras, G. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02110.x · Cited by 75 · see citing works
Takasu, N., Oshiro, C., Akamine, H., Komiya, I., Nagata, A., Sato, Y., Yoshimura, H., & Ito, K. (1997) · Journal of Endocrinological Investigation · doi:10.1007/bf03348001 · Cited by 63 · see citing works
Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin
Morimura, T., Tsunekawa, K., Kasahara, T., Seki, K., Ogiwara, T., Mori, M., & Murakami, M. (2005) · Endocrinology · doi:10.1210/en.2004-1432 · Cited by 60 · see citing works
Langdahl, B. L., Loft, A. G., Eriksen, E. F., Mosekilde, L., & Charles, P. (1996) · PubMed · doi:10.1089/thy.1996.6.161 · Cited by 55 · see citing works
Nagasaka, S., Sugimoto, H., Nakamura, T., et al. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2401045.x · Cited by 52 · see citing works
Bone mass in females with different thyroid disorders: influence of menopausal status
Campos-Pastor, M. M., Muñoz‐Torres, M., Escobar‐Jiménez, F., de Almodóvar, J. M. R., & Gimeno, E. J. (1993) · Bone and Mineral · doi:10.1016/s0169-6009(08)80115-8 · Cited by 51 · see citing works
Mizutori, Y., Chen, C., Latrofa, F., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-2134 · Cited by 48 · see citing works
Antiresorptive Therapy in Hyperthyroid Patients: Longitudinal Changes in Bone and Mineral Metabolism
Jódar, E., Muñoz‐Torres, M., Escobar‐Jiménez, F., Quesada, M., Luna, J. D. D., & Olea, N. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.6.4026 · Cited by 45 · see citing works
Evaluation of bone mineral density in thyrotoxicosis.
Udayakumar, N., Chandrasekaran, M., Rasheed, M. H., Suresh, R., & Sivaprakash, S. (2006) · PubMed · Cited by 43 · see citing works
Is previous hyperthyroidism still a risk factor for osteoporosis in post‐menopausal women?
Grant, D. J. W., McMurdo, M. E. T., Mole, P. A., & Paterson, C. R. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02041.x · Cited by 42 · see citing works
Erratum to “Cell-Type-Dependent Thyroid Hormone Effects on Glioma Tumor Cell Lines”
Liappas, A., Mourouzis, I. S., Zisakis, A., Economou, K., Lea, R.-W., & Pantos, C. I. (2012) · Journal of Thyroid Research · doi:10.1155/2012/176281 · Cited by 36 · see citing works
Concentration-dependent regulation of thyrotropin receptor function by thyroid-stimulating antibody
Ando, T., Latif, R., & Davies, T. F. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21334 · Cited by 35 · see citing works
Early postmenopausal bone loss in hyperthyroidism
Ben-Shlomo, A., Hagag, P., Evans, S., & Weiss, M. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00179-1 · Cited by 31 · see citing works
Hyperthyroidism Influences Ultrasound Bone Measurement on the Os Calcis
Gómez Acotto, C., Schott, A. M., Hans, D., Niepomniszcze, H., Mautalen, C. A., & Meunier, P. J. (1998) · Osteoporosis International · doi:10.1007/s001980050091 · Cited by 30 · see citing works
Oikawa, M., Kushida, K., Masaaki, T., Ohishi, T., Hoshino, H., Suzuki, M., Ogihara, H., ISHIGAKI, J., & Inoue, T. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00626.x · Cited by 29 · see citing works
Majima, T., Komatsu, Y., Doi, K., Takagi, C., Shigemoto, M., Fukao, A., Morimoto, T., Corners, J., & Nakao, K. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0091-4 · Cited by 24 · see citing works
Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
Zimmermann‐Belsing, T., Tofteng, C. L., Langdahl, B. L., Charles, P., & Feldt‐Rasmussen, U. (2010) · Nutrition & Metabolism · doi:10.1186/1743-7075-7-72 · Cited by 18 · see citing works
Self-citationIs Previous Hyperthyroidism Still a Risk Factor for Osteoporosis in Postmenopausal Women?
Grant, D. J. W., McMurdo, M. E. T., Mole, P. A., & Paterson, C. (1995) · Age and Ageing · doi:10.1093/ageing/24.suppl_2.p7-a · Cited by 15 · see citing works
Graves' disease: evolution and prognosis after eight months of treatment with methimazole.
At, G., Ce, G., Gc, S., et al. (1992) · PubMed · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Levothyroxine therapy in elderly patients with hypothyroidism
Effraimidis, G., Watt, T., & Feldt-Rasmussen, U. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.641560 · Cited by 60 · see citing works
“org 8 in prospective cohorts (101), while in euthyroid women with a history of Graves’ hyperthyroidism lumbar spine bone density was negatively associated with TSH receptor antibodies in postbut not premenopausal women (102).”
BackgroundSelf-citation
- Authors
- Ercolano, M. A., Drnovsek, M. L., Croome, M. C. S., Moos, M., Fuentes, A. M., Viale, F., Feldt-Rasmussen, U., & Gauna, A. T.
- Affiliations
- Hospital Ramos Mejía (AR)
- ORCID
- Gauna, Alicia T
- Venue
- Thyroid Research
- Published
- 2013
- Volume
- 6
- Issue
- 1
- Pages
- 11
- ISSN
- 1756-6614 (ISSN-L)
- PMC
- PMC3847206
- OpenAlex
- W2130828493
- Cited by
- 17
- References
- 49
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2022: 1 · 2021: 1 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 2 · 2014: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Thyroid Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- bone mineral density, TSH receptor antibodies, Graves' disease, postmenopausal women, secondary osteoporosis, bone metabolism, lumbar spine, euthyroidism, hyperthyroidism, TSH receptor, bone turnover
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review